This year’s #NMMSymposium spotlighted key advances in #neurooncology: from single-cell tech to AI imaging and immunotherapy. Topics that resonate deeply with our work at #RENACER.​ ​ 🔗 nmn-society.org/program/

El 8 de junio se conmemora el #DíaInternacionaldelosTumoresCerebrales. Estos tumores plantean enormes desafíos para la investigación. En nuestro blog te contamos por qué son tan difíciles de abordar y qué avances se están logrando. blog.contraelcancer.es/investigacion-…

Los grandes retos de la investigación en tumores cerebrales blog.contraelcancer.es/investigacion-…

We are excited to share this article from EL MUNDO, which focuses on our work to improve brain metastasis treatment. With the participation of patients, healthcare professionals, and project leaders, the article highlights the challenges of treating brain metastases and the

The 2025 EACR Congress is the key meeting for cancer researchers tackling brain metastases. Topics like tumour evolution & immune evasion are vital for advancing personalised medicine. RENACER is proud to connect teams driving this progress. 🧬 🔗 2025.eacr.org

At #RENACER, we support research that brings us closer to personalised treatments.​ This study led by Zhu et al. uses organotypic cultures to identify vulnerabilities in brain metastases. A major step forward!​ ​ 🔗 pubmed.ncbi.nlm.nih.gov/35174975/

The 5th RENACER General Assembly will connect professionals, researchers & all those interested in brain metastasis to learn about the new advances that are being developed in this field.​ 📅 Friday, Oct 24th​ 📍 Ramón Areces Foundation, Madrid​ 🕥 10:30 - 15:00 h

🧠 Brain metastases affect up to 30% of cancer patients. Yet key aspects remain poorly understood.​ MoLab's new review in Mathematical Biosciences explores how mathematical models can predict tumour growth & treatment response. ​ 🔗 sciencedirect.com/science/articl…

Dr Manuel Valiente & Dr @BenedictoC_F reflect on the brain, cancer, & the need of collaboration. From brain metastasis to science communication, they call for research with real impact. #WorldBrainDay​ ​ 🔗 Full interview: elperiodico.com/ideas/Fundacio…

The IARC and American Cancer Society have launched the 4th edition of the Cancer Atlas, a free tool with global data on cancer trends, risks & prevention. 🌍📊 At #RENACER, we’re working to address one of the toughest cancer challenges: brain metastases. 🔗 canceratlas.cancer.org

“Driving research forward isn’t just about starting projects; it’s about supporting them all the way through. In the case of RENACER, this ensures that no tumour is left behind. 🗣️Dr Niebla Priego, a postdoctoral researcher in the Brain Metastasis Group at CNIO.

🧠 New research reveals why #Immunotherapy often fails in symptomatic #BrainMetastases: some astrocytes block T-cell activity. By combining treatments, this local immunosuppression is no longer observed. A promising step towards personalized treatment! bit.ly/3IvfqLw

🧠 Save the Date! 📅 24 Oct 2025 | 🕥 10:30–15:00 📍 Fundación Ramón Areces, Madrid Join the 5th RENACER GA to share breakthroughs in #BrainMetastasis. Talks by top experts on CNS mets, lung cancer & more. 🔗 Register: bit.ly/3U4ROA3 #Oncology #RENACER

📋At #RENACER, we know biobanks can transform health care —but only with strong legal frameworks. A study reviews Spain’s biobank laws, their strengths and limitations, and how to enhance their impact. 📖 Read the full article: doi.org/10.1089/bio.20…

🆕 The AEMPS offers a monthly newsletter on oncology regulation. If you are a patient, a professional, or a researcher, stay informed of changes shaping the future of cancer by subscribing here: gob.us4.list-manage.com/subscribe?u=ab…

🔬Last September 24th was #WorldCancerResearchDay. We honor the power of research to transform cancer care. At #RENACER, we promote research as it is the basis for developing earlier diagnoses, personalising treatments and bringing hope to patients with brain metastases.

At #RENACER we thank donors and families: your generosity makes research possible, helps us understand #BrainMetastasis and paves the way for better diagnosis and treatment. 🙏 Thank you for turning your generosity into science and a better future. #EuropeanDonationDay

Radiation necrosis (RN) after stereotactic radiosurgery (SRS) can mimic tumor recurrence. A new study using computational models shows why RN grows faster & offers a growth metric to distinguish them, improving diagnosis and guiding more precise care 👇pubmed.ncbi.nlm.nih.gov/38289964/

🧠 Oct 26 is Spain’s National Day of #AcquiredBrainInjury. At #RENACER we study how brain metastasis affects memory, attention & communication. Because cancer research is not only about prolonging life, but also preserving what makes it truly livable.

Manuel Valiente (@ValienteLab) shared with the researchers at CNIO Stop Cancer the team studies about the tumour microenvironment to challenge #BrainMetastasis in mice and humans. Understanding these interactions helps turn lab discoveries into patient benefit. #ShareToAdvance